Exercise and rehabilitation
Progressive loading for early tibialis posterior tendon disease[3]
Consider when. Assessed early-stage tendon dysfunction with an appropriate plan for foot support.
Begin tolerable resisted inversion/plantar flexion and supported heel rises. A clinician adjusts the movement to maintain control and avoid collapsing into an intolerable position.
- Dose and review
- Start below the current flare threshold and progress across weeks; the trial evaluated a 12-week program, not a fixed universal dose.
- Progression
- Increase resistance and heel-rise demand when walking and next-day symptoms remain stable.
- Stop or reassess
- Stop for a sudden loss of support or new swelling; reduce load if ordinary walking worsens persistently.
- Evidence and limits
- In 36 adults with stage I/II tendon disease, adding progressive resistance to orthoses/stretching improved pain and perceived function at 12 weeks. This is tendon evidence.
Clinician-delivered care
Footwear, orthosis or brace matched to the foot[3]
Consider when. An assessed tendon/foot presentation in which support improves standing or walking.
Assess shoe fit, flexibility of the deformity and whether a foot orthosis or ankle-foot brace reduces symptoms during a repeatable walk. Review pressure areas and comfort.
- Dose and review
- Wear time and support level are individualized, with an early fit check.
- Progression
- Reassess walking, skin and strength as activity expands; support and rehabilitation can be used together.
- Stop or reassess
- Review promptly for skin breakdown, numbness or worsening deformity.
- Evidence and limits
- Orthoses formed part of the early tendon-dysfunction trial; the trial does not identify one best device for every stage or prove a muscle trigger-point effect.
Self-care and activity
Adjust standing and walking exposure[3]
Consider when. Load-related symptoms without acute injury or vascular warning signs.
Break long standing periods and choose shorter level walks that do not leave the foot persistently worse. Restore hills and uneven terrain after basic walking improves.
- Dose and review
- Use the present comfortable duration as the starting point and review the next-day response.
- Progression
- Add duration or terrain difficulty separately while maintaining the strength/support plan.
- Stop or reassess
- Reassess if pain becomes focal over bone or support deteriorates despite a reduced workload.
- Evidence and limits
- Practical load management within a tendon rehabilitation pathway; this specific walking schedule has not been tested as a tibialis-posterior MPS treatment.
Clinician-delivered care
Botulinum toxin for diagnosed tibialis posterior spasticity[6]
Consider when. Neurological spasticity, such as after stroke, in which involuntary tibialis posterior activity interferes with foot placement, shoe/brace use or gait. Ordinary cramping, tendon pain and a tender point do not establish this indication.
A rehabilitation/spasticity specialist evaluates the whole limb, passive range, weakness and the role of each involved muscle. If appropriate, use guided muscle localization and pair treatment with rehabilitation or orthotic care to address foot placement, shoe/brace use or gait.
- Dose and review
- Drug selection and dose are prescribed individually. Agree on a review around 4–6 weeks and reassess before any repeat treatment.
- Progression
- Compare the agreed functional goal and adverse effects, not tone alone; a fixed contracture or weakness may need a different strategy.
- Stop or reassess
- Report new troublesome weakness or falls. Difficulty swallowing or breathing after toxin treatment requires urgent medical help.
- Evidence and limits
- The US label supports adult lower-limb spasticity. Its 468-person post-stroke trial used several muscles and followed participants for 12 weeks; benefits in ankle tone/global response at weeks 4/6 do not establish isolated-muscle pain relief or efficacy for MPS.